Obsidian Therapeutics SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

SCHEDULE 13GOct. 5, 2026, 4:01 p.m. ETView on SEC.gov
S-1Aug. 28, 2026View on SEC.gov
8-K/AAug. 14, 2026, 4:29 p.m. ETView on SEC.gov
Financial statements and exhibits
10-QAug. 14, 2026, 4:28 p.m. ETView on SEC.gov
SCHEDULE 13GAug. 11, 2026, 4:03 p.m. ETView on SEC.gov
SCHEDULE 13GAug. 10, 2026, 4:43 p.m. ETView on SEC.gov
SCHEDULE 13GAug. 10, 2026, 4:21 p.m. ETView on SEC.gov
SCHEDULE 13GAug. 10, 2026, 4:23 p.m. ETView on SEC.gov
4Aug. 5, 2026, 4:10 p.m. ETView on SEC.gov
4Aug. 5, 2026, 4:08 p.m. ETView on SEC.gov
4Aug. 5, 2026, 4:08 p.m. ETView on SEC.gov
4Aug. 5, 2026, 4:07 p.m. ETView on SEC.gov
4Aug. 5, 2026, 4:06 p.m. ETView on SEC.gov
4Aug. 5, 2026, 4:05 p.m. ETView on SEC.gov
8-KAug. 3, 2026, 5:08 p.m. ETView on SEC.gov
Entry into a material definitive agreement · Completion of acquisition or disposition of assets · Results of operations and financial condition · Unregistered sales of equity securities · Material modification of security holders' rights · Change in certifying accountant · Change in control · Departure/appointment of directors or officers · Amendments to articles or bylaws; fiscal year change · Regulation FD disclosure · Financial statements and exhibits